Cerus (CERS) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cerus | 549.42 Mn | 469.73 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.62% |
| Dec 31, 2025 | 11.76% |
| Sep 30, 2025 | 13.78% |
| Mar 31, 2025 | 13.93% |
| Dec 31, 2024 | 13.63% |
| Sep 30, 2024 | 13.45% |
| Jun 30, 2024 | 13.80% |
| Mar 31, 2024 | 16.59% |
| Dec 31, 2023 | 21.72% |
| Sep 30, 2023 | 21.35% |
| Jun 30, 2023 | 19.06% |
| Mar 31, 2023 | 19.56% |
| Dec 31, 2022 | 18.56% |
| Sep 30, 2022 | 18.55% |
| Jun 30, 2022 | 31.91% |
| Mar 31, 2022 | 30.90% |
| Dec 31, 2021 | 29.08% |
| Sep 30, 2021 | 27.29% |
| Jun 30, 2021 | 26.38% |
| Mar 31, 2021 | 26.63% |
| Dec 31, 2020 | 19.42% |
| Sep 30, 2020 | 17.53% |
| Mar 31, 2020 | 34.97% |
| Dec 31, 2019 | 35.10% |
| Sep 30, 2019 | 35.09% |
| Jun 30, 2019 | 34.79% |
| Mar 31, 2019 | 64.56% |
| Dec 31, 2018 | 54.75% |
| Sep 30, 2018 | 52.34% |
| Jun 30, 2018 | 69.11% |
| Mar 31, 2018 | 33.79% |
| Dec 31, 2017 | 31.00% |
| Sep 30, 2017 | 29.34% |
| Jun 30, 2017 | 18.70% |
| Mar 31, 2017 | 20.24% |
| Dec 31, 2016 | 21.84% |
| Sep 30, 2016 | 31.56% |
| Jun 30, 2016 | 37.53% |
| Dec 31, 2015 | 32.34% |